- $1.45bn
- $2.85bn
- $371.02m
- 67
- 85
- 80
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 120 | 164 | 343 | 348 | 371 |
Cost of Revenue | |||||
Gross Profit | 97.5 | 127 | 282 | 285 | 303 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 68.3 | 88.8 | 144 | 163 | 164 |
Operating Profit | 51.6 | 75.6 | 200 | 185 | 207 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 17.1 | 8.19 | 162 | 188 | 120 |
Provision for Income Taxes | |||||
Net Income After Taxes | 17 | 8.11 | 162 | 188 | 120 |
Net Income Before Extraordinary Items | |||||
Net Income | 17 | 8.11 | 162 | 188 | 120 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 17 | 8.11 | 162 | 188 | 120 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.375 | 0.149 | 3.06 | 3.81 | 2.41 |
Dividends per Share | |||||
Special Dividends per Share |